The association between normal alanine aminotransferase levels and the metabolic syndrome: 2005 Korean National Health and Nutrition Examination Survey

Metabolism: Clinical and Experimental

Volumn 58, Issue 12, 2009, Pages 1731-1736

  Suh, Sang Yeon ^a   Choi, Sung Eun ^b   Ahn, Hong Yup ^c   Yang, Hye Min ^a   Kim, Yu Il ^a   Sung, Nak Jin ^a  

^a Dongguk University Ilsan Hospital   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Dongguk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ARTICLE; BODY MASS; CIGARETTE SMOKING; DATA ANALYSIS; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADULT; ALANINE TRANSAMINASE; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; FEMALE; HEALTH SURVEYS; HUMANS; KOREA; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ODDS RATIO; RISK ASSESSMENT; SEX FACTORS; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 71849084817     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.05.028     Document Type: Article

References (22)

1. Pratt D.S., and Kaplan M.M. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 342 (2000) 1266-1271
2. Vozarova B., Stefan N., Lindsay R.S., Saremi A., Pratley R.E., Bogardus C., et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51 (2002) 1889-1895
3. Hanley A.J., Williams K., Festa A., Wagenknecht L.E., D'Agostino Jr. R.B., and Haffner S.M. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 54 (2005) 3140-3147
4. Schindhelm R.K., Dekker J.M., Nijpels G., Stehouwer C.D., Bouter L.M., Heine R.J., et al. Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study. Diabet Med 24 (2007) 430-435
5. Kim H.C., Choi K.S., Jang Y.H., Shin H.W., and Kim D.J. Normal serum aminotransferase levels and the metabolic syndrome: Korean National Health and Nutrition Examination Surveys. Yonsei Med J 47 (2006) 542-550
6. Choi K.M., Lee K.W., Kim H.Y., Seo J.A., Kim S.G., Kim N.H., et al. Association among serum ferritin, alanine aminotransferase levels, and metabolic syndrome in Korean postmenopausal women. Metabolism 54 (2005) 1510-1514
7. Kim H.C., Nam C.M., Jee S.H., Han K.H., Oh D.K., and Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 328 (2004) 983
8. Jeong S.K., Nam H.S., Rhee J.A., Shin J.H., Kim J.M., and Cho K.H. Metabolic syndrome and ALT: a community study in adult Koreans. Int J Obes Relat Metab Disord 28 (2004) 1033-1038
9. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
10. Steering Committee of the Western Pacific Region of the Study of Obesity at IOTF. The Asia-Pacific perspective: redefining obesity and its treatment (2000), Health Communications Australia Pty Ltd., Melbourne
11. Bayard M., Holt J., and Boroughs E. Nonalcoholic fatty liver disease. Am Fam Physician 73 (2006) 1961-1968
12. Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004) 1387-1395
13. Petersen K.F., Dufour S., Befroy D., Lehrke M., Hendler R.E., and Shulman G.I. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54 (2005) 603-608
14. Kerner A., Avizohar O., Sella R., Bartha P., Zinder O., Markiewicz W., et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol 25 (2005) 193-197
15. Shen Y.H., Yang W.S., Lee T.H., Lee L.T., Chen C.Y., and Huang K.C. Bright liver and alanine aminotransferase are associated with metabolic syndrome in adults. Obes Res 13 (2005) 1238-1245
16. Hanley A.J., Wagenknecht L.E., Festa A., D'Agostino Jr. R.B., and Haffner S.M. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Diabetes Care 30 (2007) 1819-1827
17. Prati D., Taioli E., Zanella A., Della Torre E., Butelli S., Del Vecchio E., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137 (2002) 1-10
18. Burgert T.S., Taksali S.E., Dziura J., Goodman T.R., Yeckel C.W., Papademetris X., et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 91 (2006) 4287-4294
19. Chang Y., Ryu S., Sung E., and Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 53 (2007) 686-692
20. Wanless I.R., Bargman J.M., Oreopoulos D.G., and Vas S.I. Subcapsular steatonecrosis in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity. Mod Pathol 2 (1989) 69-74
21. Sanyal A.J., Campbell-Sargent C., Mirshahi F., Rizzo W.B., Contos M.J., Sterling R.K., et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120 (2001) 1183-1192
22. Shin H.R., Hwang S.Y., and Nam C.M. The prevalence of hepatitis C virus infection in Korea: pooled analysis. J Korean Med Sci 20 (2005) 985-988